- Home
- BMRN vs ZTO Comparison
BMRN vs ZTO Comparison
Compare BMRN & ZTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- ZTO
- Stock Information
- Founded
- BMRN 1996
- ZTO 2002
- Country
- BMRN United States
- ZTO China
- Employees
- BMRN N/A
- ZTO N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- ZTO Advertising
- Sector
- BMRN Health Care
- ZTO Consumer Discretionary
- Exchange
- BMRN Nasdaq
- ZTO Nasdaq
- Market Cap
- BMRN 12.1B
- ZTO 13.4B
- IPO Year
- BMRN 1999
- ZTO 2016
- Fundamental
- Price
- BMRN $54.97
- ZTO $17.71
- Analyst Decision
- BMRN Buy
- ZTO Buy
- Analyst Count
- BMRN 22
- ZTO 5
- Target Price
- BMRN $93.43
- ZTO $22.64
- AVG Volume (30 Days)
- BMRN 2.2M
- ZTO 1.7M
- Earning Date
- BMRN 08-04-2025
- ZTO 08-19-2025
- Dividend Yield
- BMRN N/A
- ZTO 3.95%
- EPS Growth
- BMRN 152.82
- ZTO N/A
- EPS
- BMRN 2.71
- ZTO 1.22
- Revenue
- BMRN $2,950,227,000.00
- ZTO $6,230,576,589.00
- Revenue This Year
- BMRN $12.23
- ZTO $16.57
- Revenue Next Year
- BMRN $9.99
- ZTO $12.82
- P/E Ratio
- BMRN $20.28
- ZTO $14.56
- Revenue Growth
- BMRN 19.36
- ZTO 14.76
- 52 Week Low
- BMRN $52.93
- ZTO $16.34
- 52 Week High
- BMRN $94.85
- ZTO $27.50
- Technical
- Relative Strength Index (RSI)
- BMRN 40.74
- ZTO 50.03
- Support Level
- BMRN $53.76
- ZTO $17.07
- Resistance Level
- BMRN $56.25
- ZTO $18.04
- Average True Range (ATR)
- BMRN 1.26
- ZTO 0.24
- MACD
- BMRN 0.06
- ZTO 0.08
- Stochastic Oscillator
- BMRN 28.09
- ZTO 60.40
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About ZTO ZTO Express (Cayman) Inc. each representing one ordinary share.
ZTO Express is China's largest express delivery company by parcel volume, with a volume share of 22.1% in 2022. It operates a network partner model where it provides line-haul transportation and sorting services, while its local network partners provide first-mile pickup and last-mile delivery services under the ZTO brand name. Headquartered in Shanghai, the company was founded in 2002 by Meisong Lai, who remains chair, CEO, and its major shareholder with 77% voting rights as of June 30, 2023. ZTO's strategic shareholder is leading China e-commerce company Alibaba Group with around an 11.7% interest.